J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,810.00
-160.00 (-2.01%)
At close: Jun 5, 2026

J2KBIO Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8,87512,2656,9573,9193,7444,435
Short-Term Investments
--5,111-1,000-
Trading Asset Securities
451.22435.74985.78481.71354.97488.23
Cash & Short-Term Investments
9,32612,70113,0544,4015,0994,923
Cash Growth
-12.55%-2.70%196.61%-13.68%3.56%89.61%
Accounts Receivable
7,7985,4013,5766,2453,0422,346
Other Receivables
61.6727.1434.6321.3224.2511.81
Receivables
7,8595,4283,6116,2663,0662,357
Inventory
3,8323,2732,6902,9442,3021,265
Prepaid Expenses
286.29228.4261.722.411.471.52
Other Current Assets
1,201312.94382.24267.6489.46275.45
Total Current Assets
22,50521,94419,79813,88110,5588,823
Property, Plant & Equipment
14,63014,82315,0027,5496,6136,882
Long-Term Investments
3,130491.73493.788.737.94.33
Goodwill
----6.746.74
Other Intangible Assets
442.6450.96417.07391.74189.05160.66
Long-Term Accounts Receivable
33.6733.67----
Long-Term Deferred Tax Assets
81.5981.5950.2884.76182.08210.21
Other Long-Term Assets
230.06240.05204.7799.7156.0363.47
Total Assets
41,05338,06435,96622,01517,61316,150
Accounts Payable
2,6151,3771,4261,479571.89490.28
Accrued Expenses
337.92219.71134.19140.6483.64130.81
Short-Term Debt
---100-15.6
Current Portion of Long-Term Debt
---5001,0361,053
Current Portion of Leases
278.22282.66240.39118.6367.7640.5
Current Income Taxes Payable
356.88143.43163.25670.49114.38-
Current Unearned Revenue
8.428.67----
Other Current Liabilities
2,4201,064547.54668.091,3611,348
Total Current Liabilities
6,0163,0952,5113,6773,2353,078
Long-Term Debt
4004001,2664003,3694,100
Long-Term Leases
382.26452.2581.98126.88117.338.76
Other Long-Term Liabilities
350.55345.11264.05000
Total Liabilities
7,1494,2934,6234,2046,7217,217
Common Stock
2,9242,9242,8662,530309.28309.28
Additional Paid-In Capital
15,94015,94015,117359.74285.89285.89
Retained Earnings
15,06414,93113,34214,99410,3708,342
Treasury Stock
----63-63-63
Comprehensive Income & Other
-23.33-23.3317.78-8.54-54.4-7.72
Total Common Equity
33,90433,77231,34417,81210,8478,867
Minority Interest
----0.7644.7566.6
Shareholders' Equity
33,90433,77231,34417,81110,8928,933
Total Liabilities & Equity
41,05338,06435,96622,01517,61316,150
Total Debt
1,0601,1352,0881,2464,5905,248
Net Cash (Debt)
8,26611,56610,9663,156508.96-324.19
Net Cash Growth
-12.48%5.48%247.50%520.00%--
Net Cash Per Share
1418.101985.531983.98625.86100.95-5241.22
Filing Date Shares Outstanding
5.845.855.735.044.650.06
Total Common Shares Outstanding
5.845.855.735.044.650.06
Working Capital
16,48918,84817,28710,2047,3235,745
Book Value Per Share
5804.035775.415467.403532.892330.59143349.67
Tangible Book Value
33,46233,32130,92617,42110,6528,699
Tangible Book Value Per Share
5728.265698.285394.643455.192288.53140643.33
Land
3,1923,1921,1761,1401,1401,140
Buildings
5,3315,3314,1873,9553,9553,955
Machinery
4,3764,2863,8952,3632,2102,191
Construction In Progress
2,6342,6015,572932.58--